• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

詹森型干骺端软骨发育不良中一种组成型激活的突变型甲状旁腺激素-甲状旁腺激素相关蛋白受体

A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.

作者信息

Schipani E, Kruse K, Jüppner H

机构信息

Department of Medicine, Massachusetts General Hospital 02114, USA.

出版信息

Science. 1995 Apr 7;268(5207):98-100. doi: 10.1126/science.7701349.

DOI:10.1126/science.7701349
PMID:7701349
Abstract

A single heterozygous nucleotide exchange in exon M2 of the gene encoding the parathyroid hormone-parathyroid hormone-related peptide (PTH-PTHrP) receptor was identified in a patient with Jansen-type metaphyseal chondrodysplasia, which changes a strictly conserved histidine residue at position 223 in the receptor's first intracellular loop to arginine. Constitutive, ligand-independent adenosine 3',5'-monophosphate accumulation was observed in COS-7 cells expressing the mutant PTH-PTHrP receptor but not in cells expressing the wild-type receptor. This finding explains the severe ligand-independent hypercalcemia and hypophosphatemia, and most likely the abnormal formation of endochondral bone, in this rare form of short-limbed dwarfism.

摘要

在一名患有詹森型干骺端软骨发育不良的患者中,发现甲状旁腺激素 - 甲状旁腺激素相关肽(PTH - PTHrP)受体编码基因的外显子M2中存在单个杂合核苷酸交换,该交换将受体第一个细胞内环中第223位严格保守的组氨酸残基变为精氨酸。在表达突变型PTH - PTHrP受体的COS - 7细胞中观察到组成性的、不依赖配体的3',5'-环磷酸腺苷积累,而在表达野生型受体的细胞中未观察到。这一发现解释了这种罕见的短肢侏儒症中严重的不依赖配体的高钙血症和低磷血症,以及很可能的软骨内骨异常形成。

相似文献

1
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.詹森型干骺端软骨发育不良中一种组成型激活的突变型甲状旁腺激素-甲状旁腺激素相关蛋白受体
Science. 1995 Apr 7;268(5207):98-100. doi: 10.1126/science.7701349.
2
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.詹森干骺端软骨发育不良中甲状旁腺激素和甲状旁腺激素相关肽的组成性激活受体
N Engl J Med. 1996 Sep 5;335(10):708-14. doi: 10.1056/NEJM199609053351004.
3
A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.詹森干骺端软骨发育异常中的一种新型甲状旁腺激素(PTH)/PTH相关肽受体突变。
J Clin Endocrinol Metab. 1999 Sep;84(9):3052-7. doi: 10.1210/jcem.84.9.6000.
4
Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.甲状旁腺激素(PTH)/PTH相关肽受体在詹森干骺端软骨发育不良的两个位点发生突变,导致环磷酸腺苷信号通路的组成性激活。
Mol Endocrinol. 1997 Jun;11(7):851-8. doi: 10.1210/mend.11.7.9934.
5
Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.布洛姆斯特兰德软骨发育异常中人类甲状旁腺激素1型受体基因的失活突变。
Endocrinology. 1998 Dec;139(12):5255-8. doi: 10.1210/endo.139.12.6522.
6
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.布洛姆斯特兰德软骨发育异常中甲状旁腺激素和甲状旁腺激素相关肽功能性受体的缺失。
J Clin Invest. 1998 Jul 1;102(1):34-40. doi: 10.1172/JCI2918.
7
Functional properties of the PTH/PTHrP receptor.
Bone. 1995 Aug;17(2 Suppl):39S-42S. doi: 10.1016/8756-3282(95)00206-s.
8
The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.詹森干骺端软骨发育不良中的甲状旁腺激素/甲状旁腺激素相关蛋白受体
J Endocrinol Invest. 2000 Sep;23(8):545-54. doi: 10.1007/BF03343773.
9
Jansen-type metaphyseal chondrodysplasia: analysis of PTH/PTH-related protein receptor messenger RNA by the reverse transcriptase-polymerase chain method.詹森型干骺端软骨发育不良:用逆转录-聚合酶链法分析甲状旁腺激素/甲状旁腺激素相关蛋白受体信使核糖核酸
Endocr J. 1997 Aug;44(4):493-9. doi: 10.1507/endocrj.44.493.
10
A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.甲状旁腺激素/甲状旁腺激素相关肽受体的纯合失活突变导致布洛姆斯特兰德软骨发育异常。
J Clin Endocrinol Metab. 1998 Sep;83(9):3365-8. doi: 10.1210/jcem.83.9.5245.

引用本文的文献

1
Human diseases caused by homozygous PTH1R mutations.由纯合型甲状旁腺激素1型受体(PTH1R)突变引起的人类疾病。
Front Endocrinol (Lausanne). 2025 Aug 19;16:1641292. doi: 10.3389/fendo.2025.1641292. eCollection 2025.
2
Humanized mice to model rare human diseases.用于模拟罕见人类疾病的人源化小鼠。
Proc Natl Acad Sci U S A. 2025 Jun 24;122(25):e2512731122. doi: 10.1073/pnas.2512731122. Epub 2025 Jun 16.
3
A mouse model of Jansen's metaphyseal chondrodysplasia for investigating disease mechanisms and candidate therapeutics.
用于研究疾病机制和候选治疗方法的詹森干骺端软骨发育不良小鼠模型。
Proc Natl Acad Sci U S A. 2025 Jun 10;122(23):e2500176122. doi: 10.1073/pnas.2500176122. Epub 2025 Jun 2.
4
The genetic basis of human height.人类身高的遗传基础。
Nat Rev Genet. 2025 Apr 7. doi: 10.1038/s41576-025-00834-1.
5
Allosteric mechanism in the distinctive coupling of G and G to the parathyroid hormone type 1 receptor.G蛋白与G蛋白在甲状旁腺激素1型受体独特偶联中的变构机制。
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2426178122. doi: 10.1073/pnas.2426178122. Epub 2025 Mar 26.
6
Syndromic and Non-Syndromic Primary Failure of Tooth Eruption: A Genetic Overview.综合征型和非综合征型原发性牙齿萌出失败:遗传学概述。
Genes (Basel). 2025 Jan 24;16(2):147. doi: 10.3390/genes16020147.
7
The Molecular Biology of Placental Transport of Calcium to the Human Foetus.钙向人类胎儿胎盘转运的分子生物学
Int J Mol Sci. 2025 Jan 4;26(1):383. doi: 10.3390/ijms26010383.
8
The Crosstalk Between Cartilage and Bone in Skeletal Growth.骨骼生长过程中软骨与骨之间的相互作用
Biomedicines. 2024 Nov 21;12(12):2662. doi: 10.3390/biomedicines12122662.
9
Negative feedback between PTH1R and IGF1 through the Hedgehog pathway in mediating craniofacial bone remodeling.甲状旁腺激素1型受体(PTH1R)与胰岛素样生长因子1(IGF1)之间通过刺猬信号通路产生的负反馈在介导颅面骨重塑过程中发挥作用。
JCI Insight. 2024 Dec 17;10(3):e183684. doi: 10.1172/jci.insight.183684.
10
New Insight into the genotype-phenotype correlation of PTH1R variants and primary failure of tooth eruption on an Italian Cohort.意大利队列中 PTH1R 变异与恒牙萌出失败的表型相关性的新见解。
Eur J Hum Genet. 2024 Nov;32(11):1402-1411. doi: 10.1038/s41431-024-01691-y. Epub 2024 Sep 26.